Trial Profile
Preoperative Optimization Levosimendan in Heart Failure Patients Undergoing Hip Fracture
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms OPL
- 03 Feb 2020 Status changed from recruiting to completed.
- 20 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2018.
- 29 Nov 2016 New trial record